{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:21:35Z","timestamp":1784035295977,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic inflammatory myopathies (IIMs) are a group of systemic disorders characterized by chronic autoimmune dysregulation; their hallmark is symmetric proximal muscle weakness, often with characteristic cutaneous eruptions in dermatomyositis subtypes. Anti\u2013nuclear matrix protein-2 (NXP-2) antibodies are classified as myositis-specific autoantibodies, yet their prevalence remains persistently low. Adult dermatomyositis associated with NXP-2 positivity exhibits a distinctive phenotype in terms of clinical manifestations, complications, and prognosis\u2014particularly an elevated malignancy risk\u2014and is now regarded as an independent subset within the IIMs spectrum. However, reported frequencies vary widely across cohorts, and cases complicated by rhabdomyolysis are exceedingly rare, posing major challenges to timely recognition and optimal management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a 56-year-old man who developed rhabdomyolysis syndrome after a clear precipitating event. Despite aggressive fluid resuscitation, urinary alkalinization with sodium bicarbonate, and continuous renal-replacement therapy to clear myoglobin, systemic manifestations continued to progress. A comprehensive re-evaluation led to the diagnosis of adult anti-NXP-2 antibody-positive dermatomyositis complicated by rhabdomyolysis. High-dose pulsed glucocorticoid therapy combined with supportive measures achieved disease control and gradual stabilization, allowing transfer to a specialized unit in a stable condition. During subsequent follow-up, the patient remained on low-dose glucocorticoids without any significant adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adult anti-NXP-2 antibody-positive dermatomyositis complicated by rhabdomyolysis has been documented only sporadically; its co-occurrence is estimated at &amp;lt;1%, placing it in the ultra-rare category. The precise pathogenic role of this antibody in systemic autoimmunity remains undefined, and systematic evidence linking it to rhabdomyolysis is lacking. Future multi-omic profiling and functional studies are required to determine whether the two disorders share a common mechanistic pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1730968","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:48:01Z","timestamp":1770187681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Atypical dermatomyositis with positive anti-nuclear matrix protein 2 antibodies complicated by rhabdomyolysis syndrome: a case report and literature review"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhengyi","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlan","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","article-title":"Epidemiology of the idiopathic inflammatory myopathies","volume":"19","author":"Khoo","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B5","unstructured":"Rare diseases: considerations for the development of drugs and biological products guidance for industry\n          \n          \n          2023"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and Malignancy risk in dermatomyositis patients","volume":"69","author":"Albayda","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlab071","article-title":"Pathology features of immune and inflammatory myopathies, including a polymyositis pattern, relate strongly to serum autoantibodies","volume":"80","author":"Pestronk","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20240328-00201","article-title":"Research progress on clinical characteristics of adult anti-nuclear matrix protein-2 antibody positive dermatomyositis","volume":"63","author":"Li","year":"2024","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.211234","article-title":"Clinical heterogeneity of patients with antinuclear matrix protein 2 antibody-positive myositis: A retrospective cohort study in China","volume":"49","author":"Li","year":"2022","journal-title":"J Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00356-22","article-title":"Investigating the Relationship between Nitrate, Total Dissolved Nitrogen, and Phosphate with Abundance of Pathogenic Vibrios and Harmful Algal Blooms in Rehoboth Bay, Delaware","volume":"88","author":"Rosales","year":"2022","journal-title":"Appl Environ Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00322-3","article-title":"Idiopathic inflammatory myopathies: current insights and future frontiers","volume":"6","author":"Connolly","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.42","article-title":"Treatment in myositis","volume":"14","author":"Oddis","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000748","article-title":"Nonimmune mechanisms in idiopathic inflammatory myopathies","volume":"32","author":"Loredo Martinez","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32833a5107","article-title":"Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation","volume":"13","author":"Hasselgren","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians","volume":"9","author":"Huerta-Alard\u00edn","year":"2005","journal-title":"Crit Care"},{"key":"B17","article-title":"Myoglobinuria and acute renal failure with acute polymyositis","volume":"79","author":"Pirovino","year":"1979","journal-title":"N Y State J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.237.14.1448","article-title":"Myoglobinemia in inflammatory myopathies","volume":"237","author":"Kagan","year":"1977","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2021.10.020","article-title":"Anti-NXP2 positive dermatomyositis causing rhabdomyolysis: an atypical presentation","volume":"363","author":"Shah","year":"2022","journal-title":"Am J Med Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M201440200","article-title":"The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains","volume":"277","author":"Kimura","year":"2002","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with Malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/JND-230168","article-title":"Contribution of complement, microangiopathy and inflammation in idiopathic inflammatory myopathies","volume":"11","author":"Honda","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.02.001","article-title":"Mitochondrial DNA depletion in sporadic inclusion body myositis","volume":"29","author":"Bhatt","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051446","article-title":"Mitochondrial dysfunction: A common hallmark underlying comorbidity between sIBM and other degenerative and age-related diseases","volume":"9","author":"Catal\u00e1n-Garc\u00eda","year":"2020","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2024.11.005","article-title":"Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathy","volume":"84","author":"Kim","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100544","article-title":"Extracellular adenosine induces hypersecretion of IL-17A by T-helper 17 cells through the adenosine A2a receptor","volume":"26","author":"Tokano","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13581","article-title":"Adenosine A2B receptor activation regulates the balance between T helper 17 cells and regulatory T cells, and inhibits regulatory T cells exhaustion in experimental autoimmune myositis","volume":"15","author":"Zhou","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cmet.2020.06.006","article-title":"Adenosine\/A2B receptor signaling ameliorates the effects of aging and counteracts obesity","volume":"32","author":"Gnad","year":"2020","journal-title":"Cell Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-025-09047-0","article-title":"Targeting B cells for the treatment of idiopathic inflammatory myopathy","volume":"68","author":"Liu","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/acr2.11521","article-title":"Transcriptome profiling of immune cell types in peripheral blood reveals common and specific pathways involved in the pathogenesis of myositis-specific antibody-positive inflammatory myopathies","volume":"5","author":"Sugimori","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12736","article-title":"Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets","volume":"18","author":"Haq","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.8753","article-title":"CD19-targeting CAR T cells for myositis and interstitial lung disease associated with antisynthetase syndrome","volume":"329","author":"Pecher","year":"2023","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00023-5","article-title":"CD19-targeted CAR T cells in refractory antisynthetase syndrome","volume":"401","author":"M\u00fcller","year":"2023","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/rheumatology\/kew146","article-title":"Rituximab in the treatment of inflammatory myopathies: a review","volume":"56","author":"Fasano","year":"2017","journal-title":"Rheumatol (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/1073191115606205","article-title":"Validity of the self-report psychopathy scales (SRP-III full and short versions) in a community sample","volume":"24","author":"Gordts","year":"2017","journal-title":"Assessment"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e12857","DOI":"10.1111\/cpr.12857","article-title":"Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis","volume":"53","author":"Yue","year":"2020","journal-title":"Cell Prolif"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.10.010","article-title":"Non-coding RNA basis of muscle atrophy","volume":"26","author":"Liu","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/art.38292","article-title":"Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies","volume":"66","author":"Georgantas","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:48:05Z","timestamp":1770187685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2026.1730968"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1730968","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1730968"}}